Arsenic Trioxide and Icariin Show Synergistic Anti-leukemic Activity
Authors:
- 27 February 2015
- journal article
- Published by Springer Nature in Cell Biochemistry and Biophysics
- Vol. 73 (1) , 213-219
Abstract
Although As2O3 (ATO) has been recommended as the front-line agent for treatment of acute promyelocytic leukemia (APL), particularly for relapsed or refractory APL, it has been associated with profound toxicity. Icariin is a natural compound with activity against a variety of cancers. This study was designed to investigate the effect of Icariin on APL cells and to determine whether Icariin can potentiate the antitumor activity of ATO in APL cells. Cell proliferation and apoptosis were measured using MTT assay and flow cytometry, respectively. The expression of apoptosis and proliferation-related molecules was detected by Western blotting. Reactive oxygen species (ROS) and mitochondrial membrane potential were determined with florescence staining. Icariin inhibited proliferation in a dose-dependent manner and induced apoptosis in both of the tested APL cell lines. Icariin enhanced the in vitro antitumor activity of ATO against APL. The antitumor activity of Icariin and its enhancement of the antitumor activity of ATO correlated with the increase in accumulation of intracellular ROS. Our results showed that Icariin, by increasing intracellular ROS, exhibited antitumor activity and potentiated the antitumor activity of ATO against APL. Therefore, combination treatment with Icariin and ATO might offer a novel therapeutic option for patients with APL, although further studies are needed.Keywords
This publication has 33 references indexed in Scilit:
- Icariin Synergizes with Arsenic Trioxide to Suppress Human Hepatocellular CarcinomaCell Biochemistry and Biophysics, 2013
- Icariin potentiates the antitumor activity of gemcitabine in gallbladder cancer by suppressing NF-κBActa Pharmacologica Sinica, 2012
- Icariin and its pharmaceutical efficacy: research progress of molecular mechanismJournal of Chinese Integrative Medicine, 2011
- Long-Term Remission After First-Line Single-Agent Treatment with Arsenic Trioxide of Relapsed Acute Promyelocytic Leukemia in an 8-Year-Old BoyPediatric Hematology and Oncology, 2011
- Icariin, a natural flavonol glycoside, induces apoptosis in human hepatoma SMMC-7721 cells via a ROS/JNK-dependent mitochondrial pathwayCancer Letters, 2010
- RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradationNature Cell Biology, 2008
- Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphomaBlood, 2008
- Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic TrioxideNew England Journal of Medicine, 1998
- The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locusNature, 1990
- Molecular Analysis of Acute Promyelocytic Leukemia Breakpoint Cluster Region on Chromosome 17Science, 1990